These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. Bienert TN; Trotter MJ; Arlette JP J Cutan Med Surg; 2003; 7(1):25-30. PubMed ID: 12447624 [TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery histopathology concordance. Mariwalla K; Aasi SZ; Glusac EJ; Leffell DJ J Am Acad Dermatol; 2009 Jan; 60(1):94-8. PubMed ID: 19103361 [TBL] [Abstract][Full Text] [Related]
8. Mohs micrographic surgery concordance between Mohs surgeons and dermatopathologists. Semkova K; Mallipeddi R; Robson A; Palamaras I Dermatol Surg; 2013 Nov; 39(11):1648-52. PubMed ID: 24581313 [TBL] [Abstract][Full Text] [Related]
9. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012 [TBL] [Abstract][Full Text] [Related]
10. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054 [TBL] [Abstract][Full Text] [Related]
12. How many sections are required to clear a tumor? Results from a web-based survey of margin thresholds in Mohs micrographic surgery. Cartee TV; Monheit GD Dermatol Surg; 2013 Feb; 39(2):179-86. PubMed ID: 23003667 [TBL] [Abstract][Full Text] [Related]
13. Mohs micrographic surgery for the treatment of malignant melanoma. Whalen J; Leone D Clin Dermatol; 2009; 27(6):597-602. PubMed ID: 19880047 [TBL] [Abstract][Full Text] [Related]
14. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers. Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072 [TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery: a cost analysis. Cook J; Zitelli JA J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885 [TBL] [Abstract][Full Text] [Related]
17. New embedding and staining systems PrestoCHILL and Presto stainer for application in the advancement of Mohs micrographic surgery. Orchard GE; Shams M; d'Amico C; Wojcik K; Ismail F; Mohammad M; Salih R; Shams F; Mallipeddi R Br J Biomed Sci; 2017 Oct; 74(4):203-208. PubMed ID: 28786321 [TBL] [Abstract][Full Text] [Related]
18. Mohs micrographic surgery for the treatment of melanoma. Hui AM; Jacobson M; Markowitz O; Brooks NA; Siegel DM Dermatol Clin; 2012 Jul; 30(3):503-15. PubMed ID: 22800554 [TBL] [Abstract][Full Text] [Related]
19. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites. Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755 [TBL] [Abstract][Full Text] [Related]
20. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. Zitelli JA; Brown C; Hanusa BH J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]